A daily GLP-1 pill cut body weight by up to 8.7% in a phase 3 trial in Japan
In a phase 3 trial published Oct. 30, 2026, in The Lancet Diabetes & Endocrinology, Japanese adults with obesity disease who took orforglipron, a once-daily GLP-1 pill, lost 5.9% to 8.7% of…